Below are the most recent publications written about "Immunoglobulins, Intravenous" by people in Profiles.
-
Jindal AK, Chaudhary H, Tyagi R, Rawat A, Suri D, Patra PK, Arora K, Chawla S, Vyas S, Arora M, Aggarwal R, Basu S, Bansal R, Sachdeva MUS, Gupta A, Pandiarajan V, Sankhyan N, Suthar R, Sahu JK, Singh M, Mani R, Sharma R, Saka R, Imai K, Ohara O, Nonoyama S, Hammarstr?m L, Chan KW, Lau YL, Singh S. Meningoencephalitis in primary antibody deficiency: Our experience from northwest India. J Neuroimmunol. 2022 10 15; 371:577952.
-
Costa-Carvalho BT, Sullivan KE, Fontes PM, Aim?-Nobre F, Gonzales IGS, Lima ES, Granato C, de Moraes-Pinto MI. Low Rates of Poliovirus Antibodies in Primary Immunodeficiency Patients on Regular Intravenous Immunoglobulin Treatment. J Clin Immunol. 2018 07; 38(5):628-634.
-
Perez-Lopez CJ, Arroyo E, Rodriguez M, Ortiz D, Nazario S. Disseminated Mycobacterium avium intracellulare leading to protein-losing enteropathy in an elderly man with idiopathic CD4 lymphocytopenia. Ann Allergy Asthma Immunol. 2017 Oct; 119(4):390-391.e1.
-
V?zquez-Sanabria IL, Mercado-Seda R, Varela-Rosario N, Vil? LM. Efficacy of intravenous immunoglobulins in a patient with systemic lupus erythematosus presenting with Stevens-Johnson syndrome. BMJ Case Rep. 2015 Jul 22; 2015.
-
Garnett GM, Kimball S, Melish ME, Thompson KS, Puapong DP, Johnson SM, Woo RK. Appendicitis as the presenting manifestation of Kawasaki disease. Pediatr Surg Int. 2014 May; 30(5):549-52.
-
Tremoulet AH, Pancoast P, Franco A, Bujold M, Shimizu C, Onouchi Y, Tamamoto A, Erdem G, Dodd D, Burns JC. Calcineurin inhibitor treatment of intravenous immunoglobulin-resistant Kawasaki disease. J Pediatr. 2012 Sep; 161(3):506-512.e1.
-
Hagan JB, Wasserman RL, Baggish JS, Spycher MO, Berger M, Shashi V, Lohrmann E, Sullivan KE. Safety of L-proline as a stabilizer for immunoglobulin products. Expert Rev Clin Immunol. 2012 Feb; 8(2):169-78.
-
Burns JC, Best BM, Mejias A, Mahony L, Fixler DE, Jafri HS, Melish ME, Jackson MA, Asmar BI, Lang DJ, Connor JD, Capparelli EV, Keen ML, Mamun K, Keenan GF, Ramilo O. Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease. J Pediatr. 2008 Dec; 153(6):833-8.
-
Notarangelo LD, Rawlings DJ, Sullivan KE. An exemplum of XLA. Clin Immunol. 2008 Feb; 126(2):137-9.
-
Young MH, Engleberg NC, Mulla ZD, Aronoff DM. Therapies for necrotising fasciitis. Expert Opin Biol Ther. 2006 Feb; 6(2):155-65.